Study Clinically Validates Multi-Cancer Early Detection Test
Sensitivity was 67.6 percent for Stage I to III disease for 12 prespecified cancers accounting for two-thirds of U.S. cancer deaths
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.